Abbott Laboratories (ABT)

Abbott Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	40,109	43,653	43,075	34,608	31,904
Revenue Growth (YoY)	-8.12%	1.34%	24.47%	8.48%	4.34%
Cost of Revenue	17,975	19,142	18,537	15,003	13,231
Gross Profit	22,134	24,511	24,538	19,605	18,673
Selling, General & Admin	10,949	11,248	11,324	9,696	9,765
Research & Development	2,741	2,888	2,742	2,420	2,440
Other Operating Expenses	1,966	2,013	2,047	2,132	1,936
Operating Expenses	15,656	16,149	16,113	14,248	14,141
Operating Income	6,478	8,362	8,425	5,357	4,532
Interest Expense / Income	637	558	533	546	670
Other Expense / Income	-823	-502	-319	-181	-215
Pretax Income	6,664	8,306	8,211	4,992	4,077
Income Tax	941	1,373	1,140	497	390
Net Income	5,723	6,933	7,071	4,495	3,687
Net Income Growth	-17.45%	-1.95%	57.31%	21.91%	55.70%
Shares Outstanding (Basic)	1,740	1,753	1,775	1,773	1,768
Shares Outstanding (Diluted)	1,749	1,764	1,789	1,786	1,781
Shares Change	-0.85%	-1.40%	0.17%	0.28%	0.62%
EPS (Basic)	3.28	3.94	3.97	2.52	2.07
EPS (Diluted)	3.26	3.91	3.94	2.50	2.06
EPS Growth	-16.62%	-0.76%	57.60%	21.36%	54.89%
Free Cash Flow	5,059	7,804	8,648	5,724	4,498
Free Cash Flow Per Share	2.91	4.45	4.87	3.23	2.54
Dividend Per Share	2.040	1.880	1.800	1.440	1.280
Dividend Growth	8.51%	4.44%	25.00%	12.50%	14.29%
Gross Margin	55.18%	56.15%	56.97%	56.65%	58.53%
Operating Margin	16.15%	19.16%	19.56%	15.48%	14.21%
Profit Margin	14.27%	15.88%	16.42%	12.99%	11.56%
Free Cash Flow Margin	12.61%	17.88%	20.08%	16.54%	14.10%
Effective Tax Rate	14.12%	16.53%	13.88%	9.96%	9.57%
EBITDA	10,544	12,131	12,282	8,865	7,761
EBITDA Margin	26.29%	27.79%	28.51%	25.62%	24.33%
Depreciation & Amortization	3,243	3,267	3,538	3,327	3,014
EBIT	7,301	8,864	8,744	5,538	4,747
EBIT Margin	18.20%	20.31%	20.30%	16.00%	14.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).